At a Glance 

Quick answer: Eccrine poroma dermoscopy shows a polymorphous vascular pattern  glomerular, hairpin, and linear-irregular vessels together surrounded by milky-red to white structureless areas and white interlacing haloes. No single feature confirms the diagnosis; it is the combination, read alongside the clinical picture, that distinguishes poroma from BCC, pyogenic granuloma, and amelanotic melanoma. 

What Is an Eccrine Poroma? 

An eccrine poroma is a benign adnexal tumour arising from the terminal portion of the sweat-gland duct. It typically presents as a solitary, slow-growing, pink-to-red papule or nodule, most often on the palms, soles, or lower limbs, though it can occur anywhere on the body. Lesions are usually asymptomatic but may bleed easily or feel tender when knocked. 

Because poromas are predominantly non-pigmented and vascular, they are easily mistaken for other pink lesions, both benign and malignant. That ambiguity is exactly where dermoscopy earns its place: it gives the practitioner objective structural information rather than a judgement based on colour and shape alone. 

How to Examine a Suspected Poroma 

A reliable read starts with technique. Both polarised and non-polarised dermoscopy add value: polarised light shows vascular structures and deeper features more clearly, while non-polarised light with contact fluid highlights surface detail. Apply minimal pressure vascular lesions like poroma blanch easily, and their vessels can disappear if the instrument is pressed too firmly, taking the diagnostic information with them. 

A quality dermatoscope from the DermLite range makes it straightforward to switch between polarised and non-polarised modes on the same lesion; examining in both modes routinely surfaces features that a single view can miss. 

Dermoscopic Features of Eccrine Poroma 

No single feature is pathognomonic, but several patterns recur and, taken together, point towards the diagnosis. Dermoscopedia lists branched vessels with rounded endings, white interlacing areas, yellow structureless areas, and milky-red globules as the core associated features. 

These patterns are documented in detail by Lallas et al. in their widely cited paper, “Eccrine poroma: the great dermoscopic imitator” (J Eur Acad Dermatol Venereol, 2016) a useful reference when building a mental image library for these lesions. 

Why Vascular Patterns Matter More Than Pigment 

Because poromas are non-pigmented far more often than not, the usual pigment-based melanoma criteria offer little help here. The diagnosis instead rests on reading vessel morphology and distribution which is why a careful, low-pressure examination under polarised light matters so much. Training the eye to distinguish glomerular from hairpin from arborising vessels is the single most valuable skill for assessing these lesions. 

The dermoscopic patterns are not arbitrary: they mirror the underlying histology. The rich, polymorphous vessels correspond to the tumour’s prominent vascular stroma, while the milky-red and white areas reflect its characteristic cellular islands and surrounding tissue. Understanding this correlation builds confidence in reading the image, and explains why a poroma looks so vascular under the dermatoscope in the first place. 

Vessel types at a glance: 

Differential Diagnosis and When to Biopsy 

What Poroma Can Mimic 

The reason clinicians reach for the dermatoscope is that a poroma can imitate lesions with very different implications. 

When malignancy cannot be confidently excluded, structured criteria such as those in our 7-Point Checklist for Melanoma and prompt histology remain essential. Dermoscopy narrows the differential; it does not eliminate the need for biopsy in genuinely uncertain lesions. 

When to Biopsy 

A practical rule: dermoscopy should increase, never replace, clinical caution. If a lesion shows classic poroma features and a benign history, monitoring with documented imaging is reasonable. But any lesion with atypical vessels, rapid change, ulceration, or an uncertain read warrants excision and histology. Because amelanotic melanoma sits in this differential, erring toward biopsy when in doubt is the safe course. 

Documenting a Poroma for Follow-Up 

For a lesion as ambiguous as poroma, documentation is as valuable as the initial read. A handheld dermatoscope from the DermLite range gives the magnified, polarised view needed to assess vascular patterns, while a digital system such as the MoleMax HD captures and stores that image so the lesion can be monitored, compared over time, or reviewed by a colleague. Recording the dermoscopic appearance also strengthens the clinical record if the lesion later changes or is excised. 

Poroma’s Clinical Spectrum 

The Poroid Tumour Family 

Poroma is not a single, uniform entity. It belongs to a family of poroid tumours that also includes hidroacanthoma simplex, dermal duct tumour, and poroid hidradenoma, each with its own histological emphasis but overlapping clinical and dermoscopic features. Recognising that these variants exist helps explain why the dermoscopic picture can vary from one lesion to the next, and why the diagnosis is ultimately confirmed on histology rather than on dermoscopy alone. 

Pigmented Poroma: A Diagnostic Trap 

Most poromas are pink and vascular, but a minority are pigmented observational studies report pigmentation in roughly 17% of cases. These darker lesions are the most treacherous, because they can closely resemble melanoma or pigmented basal cell carcinoma on both clinical and dermoscopic examination. Pigmented poromas may show blue-grey or brown structures alongside the usual vascular patterns, and this combination should lower the clinician’s threshold for biopsy considerably. When pigment enters the picture, the safest assumption is that the lesion needs histological confirmation. 

This is a good example of why dermoscopy is best understood as a triage tool. It sorts lesions into “confidently benign,” “confidently in need of excision,” and “uncertain” and it is the uncertain group, where pigmented poroma often sits, that benefits most from documented imaging and specialist review. 

Key Takeaways 

• Eccrine poroma is benign but a frequent mimic of malignant lesions, so it deserves careful assessment. 

• A polymorphous vascular pattern, milky-red areas, and white haloes are the most useful dermoscopic clues none is definitive alone. 

• The critical exclusions are amelanotic melanoma and basal cell carcinoma. 

• Any atypical, pigmented, ulcerated, or rapidly changing lesion should be biopsied. 

• Dermoscopy should sharpen clinical judgement, not override it; documenting the lesion with digital imaging protects both patient and practitioner over time. 

For clinicians building their dermoscopy skills, poroma is a useful teaching lesion precisely because it forces attention onto vascular reading rather than pigment a skill that pays off across the whole spectrum of non-pigmented tumours. Dermoscopedia and DermNet offer extensive image libraries for comparison as you develop that eye. 

Frequently Asked Questions 

What is poroma dermatoscopia (poroma dermoscopy)?  

It’s the dermoscopic examination of an eccrine poroma using a dermatoscope to reveal the lesion’s vascular pattern and surface structures, which are not visible to the naked eye and help distinguish it from malignant look-alikes. 

Is poroma ecrino the same as eccrine poroma?  

Yes, poroma ecrino is the Spanish term for eccrine poroma, a benign tumour of the sweat-gland duct. 

Can dermoscopy alone confirm eccrine poroma?  

No. Dermoscopy narrows the differential and raises or lowers suspicion, but histology is required for definitive diagnosis, particularly when any atypical or pigmented feature is present. 

What is the most important feature to rule out on dermoscopy?  

Ruling out amelanotic melanoma is the priority atypical polymorphous vessels or any diagnostic uncertainty should lower the threshold for biopsy. 

Are all eccrine poromas pink? No. Most are pink and vascular, but pigmented variants occur in roughly 17% of cases and carry a higher risk of being mistaken for melanoma or pigmented basal cell carcinoma. 

See Dermoscopic Imaging in Practice 

Book a free 15-minute MoleMax demo and our specialist team will show you high-resolution capture, lesion tracking, side-by-side comparison, and structured reporting on real cases — and answer any questions specific to your practice. 

The post Eccrine Poroma Dermoscopy: Features, Patterns & Diagnosis  appeared first on MoleMax Systems.

This guide is a buying and equipment guide: it compares the categories of skin cancer detection devices on the market, what to evaluate before purchasing, and where the MoleMax range fits. It intentionally does not re-explain how AI lesion analysis works step by step for that mechanism see our in-depth explainer, AI Skin Cancer Detection System: How It Works and Why Clinics Are Adopting It. 

What Counts as a Skin Cancer Detection Device 

Three equipment families cover most clinical use: 

• Handheld dermatoscopes magnify and illuminate a single lesion for immediate visual assessment. They capture nothing automatically unless paired with a camera or phone. 

• Digital dermoscopy systems capture, store and track images across visits, turning a one-off look into a longitudinal record. 

• Point-of-care adjunctive devices use a non-imaging technology spectroscopy or impedance measurement rather than a photograph, to score a single lesion’s risk at the point of contact. 

Most dermatology clinics combine the first two. The third category is newer and sits mainly in primary care; the section below places it in context. 

The Device Landscape, by Category 

Knowing where a product sits in the wider market helps when a demo or a sales conversation starts comparing systems. 

These adjunctive devices are built for a different setting primary care triage of a single concerning lesion rather than the ongoing, whole-body monitoring that a dermatology or skin-cancer clinic typically needs. For a deeper comparison of AI-based melanoma detection systems, accuracy figures and limitations, see our AI Melanoma Detection System for Clinics: A 2026 Guide. 

Total Body vs. Single-Lesion Imaging, in Brief 

Single-lesion dermoscopy zooms in on one spot; total body photography records the whole skin surface so new or changing lesions stand out at a glance on the next visit. Most well-equipped clinics run both, linking an overview image to a detailed dermoscopic capture of anything worth a closer look. 

For the full mechanics of mole mapping, total body photography, dermoscopy and change tracking together, see Mole Mapping Technology: What It Is, How It Works, and Why Clinics Are Adopting It. 

Where the MoleMax Range Fits 

A practice can start with a MoleMax Lite and move up to a MoleMax HD or HD PRO as patient volume and total-body-mapping needs grow, without discarding the initial investment. 

What to Evaluate Before Buying 

On cost: not every system in this category charges a subscription  confirm this specifically, since it materially changes total cost of ownership over a 3–5 year horizon, not just the headline price. 

Why This Matters for Outcomes 

Cancer Australia reports an overall 94% five-year relative survival rate for melanoma diagnosed in 2017–2021. Survival varies sharply by stage at diagnosis: Cancer Council Australia cites close to 100% five-year survival for Stage I melanoma, falling to roughly 26% for Stage IV. The American Academy of Dermatology similarly recommends regular skin self-exams and professional skin checks as central to catching melanoma while it is still thin and localised. 

Digital monitoring doesn’t replace clinical judgement, but it directly supports this stage-at-diagnosis effect: a stored image history makes a slow-changing lesion visible months before it would otherwise prompt a visit. For how AI-assisted systems perform against dermatologists of varying experience in realistic settings, including the gap between expert and novice readers, see our clinical-evidence review, Limits of Artificial Intelligence Models for Skin Cancer Diagnosis in Realistic Settings. 

Fitting a Device Into the Clinic Day 

A typical rollout: capture a baseline full-body image set at a patient’s first skin check, dermoscopically image any lesion of concern, then schedule a follow-up so the same lesions are re-examined and compared automatically. With proper training, most clinics integrate digital dermoscopy within a few weeks, and the documentation time saved tends to offset the learning curve quickly. 

Being able to show a patient a magnified image of their own lesion and explain what’s being monitored and why also improves follow-up attendance, which matters as much for outcomes as the imaging itself. 

Common Procurement Questions 

Do I need a full digital dermoscopy system, or is a dermatoscope enough? For occasional checks, a handheld dermatoscope is usually enough. Clinics screening regularly, or monitoring high-risk patients over time, get the most value from digital capture with change tracking. 

Is a subscription required? Not with every system. Some digital dermoscopy platforms, including the MoleMax range, are offered without ongoing subscription fees. Confirm this before comparing headline prices, since it changes the multi-year cost picture considerably. 

Can I start small and upgrade later? Yes, within the same product family, a MoleMax Lite deployment can move to a MoleMax HD or HD PRO as volume grows, without re-doing the initial setup. 

How long does staff training take? Most clinics report confident daily use within a few weeks of onsite or remote training; exact timing depends on how much the team documents today versus on paper. 

Does total body mapping require a dedicated room? The motorised total-body-mapping stand used with systems like the MoleMax HD PRO needs a fixed, consistent-lighting space; a lighter dermoscopy-only setup does not. 

See It in Your Own Workflow 

Book a free 15-minute MoleMax demo to see high-resolution capture, lesion tracking, side-by-side comparison and structured reporting on real cases, and get your specific procurement questions answered. 

The post Skin Cancer Detection Devices: A Clinic Buyer’s Guide to Screening Equipment (2026)  appeared first on MoleMax Systems.

The post Rethinking Melanocytic Tumors: A Critical Appraisal of the WHO Classification and the Myth of Nevus-to-Melanoma Progression appeared first on MoleMax Systems.

JAMA Dermatol. Published online March 19, 2025. doi:10.1001/jamadermatol.2025.0128

Key Points

Question  In cutaneous squamous cell carcinoma, how is the number of risk factors associated with the risk of recurrence, metastasis, and disease related death?

Findings  In this cohort study of 16 844 cases of cutaneous squamous cell carcinoma, tumors were stratified by the number of the following risk factors (0, 1, 2, 3, or 4): a diameter of 2 cm or larger, poorly differentiated histology, tumor extension beyond subcutaneous fat, and large caliber nerve invasion. Every incremental increase in the number of risk factors was associated with a greater risk of local recurrence, metastasis, and disease-related death.

Meaning  The study results suggest that among individuals with cutaneous squamous cell carcinomas, the number of risk factors is an important indicator of risk.

To read the full article please click here.

The post Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma appeared first on MoleMax Systems.

The post Saving lives through the early detection of skin cancer appeared first on MoleMax Systems.

Abstract

The post Balancing the risks and benefits of sun exposure: A revised position statement for Australian adults appeared first on MoleMax Systems.

To read the full article, click here.

The post Inflammoscopy appeared first on MoleMax Systems.

Published in BMJ Open, the research led by Professor Anne Cust, deputy director of the Daffodil Centre at the University of Sydney, used data from the Bettering the Evaluation and Care of Health study between April 2000 and March 2016.  

Most startling are the overall management rates which show 3% of GP patient encounters are for skin cancer-related conditions, with solar keratosis (29.87%) and keratinocyte cancer (24.85%) the most frequent, followed by other skin lesions (12.93%), nevi (10.98%), skin check (10.37%), benign skin lesions (8.76%), and melanoma (2.42%). 

To read the full article, click here.

The post GPs managing more and more skin cancers appeared first on MoleMax Systems.

Elvira Moscarella; Pascale Guitera; Richard A. Scolyer; Lilian Rocha; Luc Thomas; Andrea Ronchi; Camila Scharf; Gabriella Brancaccio; Giuseppe Argenziano

Introduction: Melanoma on the head/neck area can show subtle clinical, dermoscopic and histologic features at early stages, being difficult to differentiate from junctional nevi.

Objectives: This case series aims to raise awareness on the topic of misdiagnosis of early lentigo maligna as junctional nevi.

To read the full article, click here

The post Junctional Nevus and Early Melanoma on Sun-Damaged Skin of the Head/Neck: A Clinico-Pathologic Challenge appeared first on MoleMax Systems.

Introduction: Differentiating early melanoma from other flat pigmented lesions on the head and neck is challenging both clinically and dermoscopically, partly due to the wide differential diagnosis and the lack of specific diagnostic algorithms.

Objectives: To review publications covering the dermoscopic features of pigmented macules on the head and neck.

Methods: Embase and PubMed (Medline) database from January 2015 to January 2021 were searched using a four-step search. Keywords used were dermoscopy/dermatoscopy or epiluminescence microscopy, lentigo maligna, lentigo maligna melanoma, lichen-planus-like-keratosis, solar lentigo, seborrheic keratosis, pigmented actinic keratosis (PAK), pigmented Bowen disease (pBD), pigmented intraepidermal carcinoma (pIEC) and head and neck.

Results: The commonest reported dermoscopic features of facial melanoma were irregular dots, atypi-cal dots/globules, asymmetric pigmented follicular openings, rhomboid gray/ black structures, increased vascular network, brown globules/dots and a pattern of circles.  Pseudopods, radial streaming, blue white veil, irregular blotches, scar-like depigmentation and atypical pigment network were recorded in low frequencies. For PAK, pBD and pIEC perifollicular erythema, white/yellow surface scale, linear wavy vessels around hair follicles, hair follicular openings surrounded by a white halo, evident follicles or follicular or keratotic plugs, rosette sign and sharply demarcated borders were the salient features.

Conclusions: Further studies are needed to determine the dermoscopic criteria for pigmented melano-cytic and non-melanocytic lesions on the head and neck. Furthermore, there is a gap in the knowledge of site-specific dermoscopic features on specific sites, namely ears, nose, cheeks, scalp and neck which will also benefit from further studies.

To read the full article click here.

The post Pigmented Macules on the Head and Neck: A Systematic Review of Dermoscopy Features appeared first on MoleMax Systems.